17 April 2025 - Dermatology company Sol-Gel Technologies Ltd (NASDAQ:SLGL) revealed on Thursday that it has entered into a product purchase agreement with a subsidiary of Mayne Pharma Group Limited (ASX:MYX) for the sale and exclusive license of the ...
17 April 2025 - Biopharmaceutical company Hoth Therapeutics Inc (NASDAQ:HOTH) announced on Thursday that it has been granted a key patent by the Japan Patent Office, expanding its global intellectual property portfolio in RNA-based precision oncology...
17 April 2025 - Clario, a US-based provider of endpoint data solutions to the clinical trial industry, announced on Wednesday a multi-year agreement with Amazon Web Services (AWS) to advance its generative AI platform.By leveraging AWS's AI and ...
17 April 2025 - South Korea-based Mezzion Pharmaceuticals, a developer of therapies for patients with single ventricle heart disease, announced on Wednesday a positive development for the Fontan community with the introduction of new, dedicated ICD-1...
17 April 2025 - Indian pharmaceutical company Zydus Lifesciences (NSE:ZYDUSLIFE) announced on Wednesday that its venture capital arm Zynext Ventures USA LLC has invested in Feldan Therapeutics, a Canadian early clinical-stage pharmaceutical company f...